| Authors: |
Bates JS; Jill S. Bates, PharmD National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Department of Practice Advancement and Clinical Education, The University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, Pharmacy Service, Durham VA Medical Center, Durham, NC; Jennifer Piccolo, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, William S. Middleton Memorial Veterans Hospital, Madison, WI; Bailey Crandall, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, Ralph H. Johnson VA Medical Center, Charleston, SC; and Michael J. Kelley, MD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Hematology-Oncology, Durham VA Medical Center, Durham, NC, Department of Medicine, Duke Cancer Institute & Medical Oncology, Duke University, Durham, NC., Piccolo J; Jill S. Bates, PharmD National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Department of Practice Advancement and Clinical Education, The University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, Pharmacy Service, Durham VA Medical Center, Durham, NC; Jennifer Piccolo, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, William S. Middleton Memorial Veterans Hospital, Madison, WI; Bailey Crandall, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, Ralph H. Johnson VA Medical Center, Charleston, SC; and Michael J. Kelley, MD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Hematology-Oncology, Durham VA Medical Center, Durham, NC, Department of Medicine, Duke Cancer Institute & Medical Oncology, Duke University, Durham, NC., Crandall B; Jill S. Bates, PharmD National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Department of Practice Advancement and Clinical Education, The University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, Pharmacy Service, Durham VA Medical Center, Durham, NC; Jennifer Piccolo, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, William S. Middleton Memorial Veterans Hospital, Madison, WI; Bailey Crandall, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, Ralph H. Johnson VA Medical Center, Charleston, SC; and Michael J. Kelley, MD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Hematology-Oncology, Durham VA Medical Center, Durham, NC, Department of Medicine, Duke Cancer Institute & Medical Oncology, Duke University, Durham, NC., Kelley MJ; Jill S. Bates, PharmD National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Department of Practice Advancement and Clinical Education, The University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, Pharmacy Service, Durham VA Medical Center, Durham, NC; Jennifer Piccolo, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, William S. Middleton Memorial Veterans Hospital, Madison, WI; Bailey Crandall, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, Ralph H. Johnson VA Medical Center, Charleston, SC; and Michael J. Kelley, MD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Hematology-Oncology, Durham VA Medical Center, Durham, NC, Department of Medicine, Duke Cancer Institute & Medical Oncology, Duke University, Durham, NC. |
